DRKS00029565招募中不适用
Circulating tumor cells to predict survival and monitor treatment response in patients with advanced HCC - CATCH
Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 70 人开始时间: 2022年7月5日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Male and female patients.
- •2. Age =18 years.
- •3. Patients with a histological/cytological or radiological diagnosis of HCC.
- •4. Patient informed consent.
排除标准
- •1. Inability to provide written informed consent.
研究者
相似试验
招募中
不适用
The study of circulating tumor cells as prognostic factor and response evaluation for pancreatic and biliary tract cancerPancreatic cancer and biliary tract cancerJPRN-UMIN000007333Yokohama City University Graduate School of Medicine100
已完成
Unknown
INTENT_Circulating tumor cells as biomarkers for recurrence risk in thermoablatioC22.0Liver cell carcinomaDRKS00016808Klinikum der Universität München, Campus Großhadern100
已完成
不适用
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsNasopharyngeal NeoplasmsNCT02505139Sun Yat-sen University166
已完成
3 期
Circulating Tumor Cells (CTCs) A prognostic biomarker in Patients with Hepatocellular CarcinomaCirculating tumor cells, liquid biopsy, hepatocellular carcinoma, biomarkerHepatocellular carcinomaTCTR20211226001/A73
招募中
Unknown
THE ROLE OF CIRCULATING TUMOUR CELLS AS EARLY PREDICTORS OF TUMOUR RECURRENCE AFTER SURGERY FOR HEPATOCELLULAR CARCINOMACTRI/2023/04/051771MOHAMED RELA